Raub Brock Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,980
| Closed | -$267K | – | 65 |
|
|
2022
Q2 | $267K | Hold |
2,980
| – | – | 0.05% | 57 |
|
|
2022
Q1 | $331K | Buy |
+2,980
| New | +$315K | 0.06% | 52 |
|
|
2021
Q2 | – | Sell |
-210,290
| Closed | -$24.8M | – | 58 |
|
|
2021
Q1 | $24.8M | Sell |
210,290
-1,806
| -0.9% | -$212K | 3.92% | 18 |
|
|
2020
Q4 | $24.8M | Sell |
212,096
-1,882
| -0.9% | -$207K | 4.03% | 15 |
|
|
2020
Q3 | $22.2M | Buy |
213,978
+1,009
| +0.5% | +$101K | 3.77% | 18 |
|
|
2020
Q2 | $19.5M | Sell |
212,969
-2,152
| -1% | -$206K | 3.63% | 20 |
|
|
2020
Q1 | $19.4M | Sell |
215,121
-2,550
| -1% | -$271K | 4.23% | 13 |
|
|
2019
Q4 | $24.7M | Buy |
217,671
+3,393
| +2% | +$372K | 4.33% | 11 |
|
|
2019
Q3 | $23.3M | Buy |
214,278
+2,782
| +1% | +$290K | 4.48% | 8 |
|
|
2019
Q2 | $20.6M | Sell |
211,496
-2,651
| -1% | -$242K | 4.21% | 14 |
|
|
2019
Q1 | $19.5M | Buy |
214,147
+5,982
| +3% | +$535K | 4.1% | 17 |
|
|
2018
Q4 | $18.9M | Buy |
208,165
+4,420
| +2% | +$413K | 4.67% | 6 |
|
|
2018
Q3 | $20M | Sell |
203,745
-2,004
| -1% | -$185K | 4.43% | 9 |
|
|
2018
Q2 | $17.6M | Buy |
205,749
+9,283
| +5% | +$775K | 4.16% | 12 |
|
|
2018
Q1 | $15.8M | Buy |
196,466
+7,220
| +4% | +$596K | 3.92% | 16 |
|
|
2017
Q4 | $15.3M | Sell |
189,246
-3,602
| -2% | -$288K | 3.78% | 17 |
|
|
2017
Q3 | $15M | Buy |
192,848
+14,065
| +8% | +$1.17M | 3.84% | 15 |
|
|
2017
Q2 | $15.9M | Buy |
178,783
+2,737
| +2% | +$231K | 4.42% | 7 |
|
|
2017
Q1 | $14.2M | Buy |
176,046
+17,920
| +11% | +$1.4M | 4.15% | 12 |
|
|
2016
Q4 | $11.3M | Sell |
158,126
-10,610
| -6% | -$834K | 3.46% | 16 |
|
|
2016
Q3 | $14.6M | Sell |
168,736
-13,233
| -7% | -$1.15M | 4.54% | 2 |
|
|
2016
Q2 | $15.8M | Sell |
181,969
-16,401
| -8% | -$1.33M | 4.74% | 1 |
|
|
2016
Q1 | $14.9M | Buy |
198,370
+2,225
| +1% | +$168K | 4.4% | 8 |
|
|
2015
Q4 | $15.1M | Buy |
196,145
+4,323
| +2% | +$325K | 4.81% | 8 |
|
|
2015
Q3 | $12.8M | Buy |
191,822
+1,462
| +0.8% | +$108K | 4.33% | 9 |
|
|
2015
Q2 | $14.1M | Buy |
190,360
+4,707
| +3% | +$360K | 4.58% | 6 |
|
|
2015
Q1 | $14.5M | Sell |
185,653
-3,151
| -2% | -$239K | 4.91% | 5 |
|
|
2014
Q4 | $13.6M | Buy |
188,804
+1,225
| +0.7% | +$85.1K | 4.76% | 5 |
|
|
2014
Q3 | $11.6M | Sell |
187,579
-1,045
| -0.6% | -$66.4K | 4.17% | 8 |
|
|
2014
Q2 | $12M | Buy |
188,624
+4,783
| +3% | +$291K | 4.53% | 4 |
|
|
2014
Q1 | $11.3M | Buy |
183,841
+11,715
| +7% | +$682K | 4.33% | 5 |
|
|
2013
Q4 | $9.88M | Buy |
172,126
+2,654
| +2% | +$150K | 4.24% | 9 |
|
|
2013
Q3 | $9.02M | Buy |
169,472
+7,095
| +4% | +$382K | 4.22% | 7 |
|
|
2013
Q2 | $8.36M | Buy |
+162,377
| New | +$8.03M | 4.3% | 4 |
|
Other funds holding MDT
Raub Brock Capital Management's MDT Position: Q3 2022 in Review
Raub Brock Capital Management sold out of Medtronic (MDT) in Q3 2022, closing a stake of 2,980 shares — an estimated $267K sold.
Raub Brock Capital Management first reported a position in MDT in Q2 2013 and held it in 34 quarters. The position peaked at $24.8M in Q4 2020. 1,930 funds tracked by Wall St. Rank hold MDT as of Q3 2022.
- Raub Brock Capital Management reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
- Raub Brock Capital Management sold 2,980 Medtronic shares in Q3 2022, an estimated $267K.
- Raub Brock Capital Management first reported a position in Medtronic in Q2 2013 and held it in 34 quarters.
- Raub Brock Capital Management's Medtronic position peaked at $24.8M in Q4 2020.
- 1,930 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.
Based on Raub Brock Capital Management's 13F filing for Q3 2022, filed 13 Oct 2022.